Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models

Neuroscience and Biobehavioral Reviews

Volumn 23, Issue 7, 1999, Pages 993-1010

  Laviola, Giovanni ^a   Adriani, Walter ^a   Terranova, M Livia ^a   Gerra, Gilberto ^b  

^a Sect of Behavioural Pathophysiology   (Italy)

^b Addiction Research Center   (Italy)

Author keywords

Animal models; Behavioural sensitization; Cocaine; d Amphetamine; Developmental plasticity; Ecstasy; Incentive motivation; Individual vulnerability; Novelty seeking; Ontogeny of behavior; Periadolescence; Rodents; Stereotypies

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; DEXAMPHETAMINE; HYDROCORTISONE; NEUROHORMONE; PROLACTIN; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILD; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; HORMONE RESPONSE; HUMAN; MUSCULOSKELETAL SYSTEM; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PSYCHOBIOLOGY; RISK FACTOR; SENSITIZATION; STEREOTYPY;

ADOLESCENT; AGING; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; EXPLORATORY BEHAVIOR; HUMANS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0032692268     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(99)00032-9     Document Type: Article

References (143)

1. Compas B.E., Hinden B.R., Gerhardt C.A. Adolescent development: pathways and processes of risk and resilience. Annu Rev Psychol. 46:1995;265-293.
2. Gerra G., Zaimovic A., Giucastro G., Maestri D., Monica C., Sartori R., caccavari R., Delsignore R. Serotonergic function after ±3,4-methylene-dioxymethamphetamine (ecstasy) in humans. Int Clin Psychopharmacology. 13:1998;1-9.
3. Witt E.D. Mechanisms of alcohol abuse and alcoholism in adolescents: a case for developing animal models. Behav Neural Biol. 62:1994;168-177.
4. Dellu F., Piazza P.V., Mayo W., Le Moal M., Simon H. Novelty-seeking in rats: biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology. 34:1996;136-145.
5. Laviola G., Terranova M.L. The developmental psychobiology of behavioural plasticity in mice: the role of social experiences in the family unit. Neurosci Biobehav Rev. 23:1998;197-213.
6. Mathias R. Students' use of marijuana, other illicit drugs, and cigarettes continued to rise in 1995. NIDA Notes. 11:1996;8-9.
7. Yamaguchi K., Kandel D.B. Patterns of drug use from adolescence to young adulthood. III. Predictors of progression. Am J Publ Health. 74:1984;673-681.
8. Newcomb M.D. Identifying high-risk youth: prevalence and patterns of adolescent drug abuse. NIDA Res Mon Series. 156:1985;7-37.
9. Adriani W., Laviola G. A unique hormonal and behavioral hyporesponsivity to both forced novelty and d-amphetamine in periadolescent mice. Neuropharmacology. 1999;. in press.
10. Bolanos C.A., Glatt S.J., Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Dev Brain Res. 111:1998;25-33.
11. Spear L.P., Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol. 16:1983;83-109.
12. Anthony J.C., Petronis K.R. Early-onset drug use and risk of later drug problems. Drug Alcohol Dep. 40:1995;9-15.
13. Breslau N., Peterson E.L. Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Pub Health. 86:1996;214-220.
14. Zuckerman M. Behavioral expressions and biosocial bases of sensation seeking. 1994;Cambridge University Press, Cambridge, MA.
15. Wills T.A., Vaccaro D., McNamara G. Novelty seeking, risk taking and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Ab. 6:1994;1-20.
16. Arnett J. Reckless behavior in adolescence: a developmental perspective. Dev Rev. 12:1992;339-373.
17. Zuckerman M. The psychobiological model for impulsive unsocialized sensation seeking: a comparative approach. Neuropsychobiology. 34:1996;125-129.
18. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennet E.R., Nemanov L., Katz M., Belmaher R.H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genet. 12:1996;78-80.
19. Netter P., Hennig J., Roed I.S. Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology. 34:1996;155-165.
20. McCann U.D., Ridenour A., Shaham Y., Ricaurte G.A. Serotonin neurotoxicity after ±3,4-methylene-dioxymethamphetamine (MDMA, ecstasy): a controlled study in humans. Neuropsychopharmacology. 10:1994;129-138.
21. Randall T. Ecstasy-fueled rave parties become dances of death for English youths. Journal of the American Medical Association. 269:1992;1505-1506.
22. Ricaurte G.A., DeLanney L.E., Irwin I., Langston J.W. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res. 446:1988;165-168.
23. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther. 240:1987;1-7.
24. Brodkinn J., Malyala A., Nash J.F. Effect of acute monoamine depletion on 3,4-methylene-dioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav. 45:1993;647-653.
25. Cadet J.L., Ladenheim B., Hirata H., Rothman R.B., Ali S., Carlson E. Superoxide radicals mediate the biochemical effects of methylene-dioxymethamphetamine (MDMA): evidence from using CUZn-superxide dismutase transgenic mice. Synapse. 21:1995;169-176.
26. McCann U.D., Ricaurte G.A. Reinforcing subjective effects of ±3,4-methylene-dioxymethamphetamine (ecstasy) may be separable from its neurotoxic actions: clinical evidence. J Clin Psychopharmacol. 13:1993;214-217.
27. Gerra G., Zaimovic A., Chittolini B., Giucastro G., Palladino M., Gaggiotti M.T., Caccavari R. Methylene-dioxymethamphetamine: neuroendocrine and behavioural aspects (in italian). Quaderno di Psichiatria. 3:1996;159-167.
28. Green A.R., Cross A.J., Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylene-dioxymethamphetamine (MDMA or ecstasy). Psychopharmacology. 119:1995;247-260.
29. Greer G., Strassman R.J. Information on ecstasy (letter). Am J Psychiatry. 142:1985;1391.
30. Solowij N., Hall W., Lee N. Recreational MDMA use in Sydney: a profile of ecstasy users and their experiences with the drug. Br J Addiction. 87:1992;1161-1172.
31. Katz M.M., Maas J.W., Frazer A., Koslow S.H., Bowden C.L., Berman N., et al. Drug-induced actions on brain neurotransmitter system and changes in the behaviors and emotions of depressed patients. Neuropsychpharmacology. 11:1994;89-100.
32. Young L.T., Warsh J.J., Kish S.J., Shannak K., Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry. 35:1994;121-127.
33. Jerison H.J. Evolutionary biology of intelligence: the nature of the problem. Jeriso H.J., Jerison I. Intelligence and evolutionary biology. 1988;1-11 Springer, Berlin.
34. Renner M.J., Seltzer C.P. Molar characteristics of exploratory and investigatory behavior in the rat (Rattus norvegicus). J Comp Psychol. 105:1991;326-339.
35. Wilz K.J., Bolton R.L. Exploratory behavior in response to the spatial rearrangement of familiar stimuli. Psychon Sci. 24:1971;117-118.
36. Rebec G.V., Christiansen J.R.C., Guerra C., Bardo M.T. Phasic increases in extracellular dopamine during a free-choice novelty task as measured by fast-scan voltammetry. Soc Neurosci Abstr. 22:1996;159.
37. Fink J.S., Smith G.P. Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats. Neurosci Lett. 17:1980;61-65.
38. Pierce C.R., Crawford C.A., Nonneman A.J., Mattingly B.A., Bardo M.T. Effects of forbrain dopamine depletion on novelty-induced place preference behavior in rats. Pharmacol Biochem Behav. 36:1990;321-325.
39. Hoebel B.G., Monaco A.P., Hernandez L., Aulisi E.F., Stanley B.G., Lenard L. Self-injection of amphetamine directly into the brain. Psychopharmacology. 81:1983;158-163.
40. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 6:1996;228-236.
41. Roberts D.C., Corcoran M.E., Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacology Biochemistry and Behavior. 6:1977;615-620.
42. Wise R.A. Neurobiology of addiction. Curr Opin Neurobiol. 6:1996;243-251.
43. Renner M.J. Neglected aspects of exploratory and investigatory behavior. Psychobiology. 18:1990;16-22.
44. Bardo M.T., Neisewander J.L., Pierce R.C. Novelty-induced place preference behavior in rats: effect of opiate and dopaminergic drugs. Pharmacol Biochem Behav. 32:1988;683-689.
45. Misslin R., Ropartz P. Effects of metamphetamine on novelty-seeking behavior by mice. Psychopharmacology. 75:1981;39-43.
46. Adriani W., Chiarotti F., Laviola G. Elevated novelty seeking and typical d-amphetamine sensitization in periadolescent compared to adult mice. Behav Neurosci. 112:1998;1152-1166.
47. Cirulli F., Terranova M.L., Laviola G. Affiliation in periadolescent rats: behavioral and corticosterone response to social reunion with familiar and unfamiliar partners. Pharmacol Biochem Behav. 54:1996;99-105.
48. Meaney M.J., Stewart J. A descriptive study of social development in the rat (Rattus norvegicus). Animal Behav. 29:1981;34-45.
49. Panksepp J. The ontogeny of play in rats. Dev Psychobiol. 14:1981;327-332.
50. Terranova M.L., Cirulli F., Laviola G. Behavioral and hormonal effects of partner familiarity in periadolescent rat pairs upon novelty exposure. Psychoneuroendocrinology. 24:1999;639-656.
51. Terranova M.L., Laviola G., Alleva E. Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes. Dev Psychobiol. 26:1993;467-481.
52. Terranova M.L., Laviola G., DeAcetis L., Alleva E. A description of the ontogeny of mouse agonistic behavior. J Comp Psychol. 112:1998;3-12.
53. Thor D.H., Holloway W.R. Developmental analyses of social play behavior in juvenile rats. Bull Psychon Soc. 22:1984;587-590.
54. Williams E., Scott J.P. The development of social behavior patterns in the mouse, in relation to natural periods. Behaviour. 6:1953;35-65.
55. Barkley M.S., Goldman B.D. A quantitative study of serum testosterone, sex accessory organ growth, and the development of intermale aggression in the house mouse. Horm Behav. 8:1977;208-218.
56. Benton D., Brain P.F. Behavioural comparison of isolated, dominant and subordinate mice. Behav Proc. 4:1979;211-219.
57. Bronson F.H. Mammalian reproductive biology. 1989;University of Chicago Press, Chicago.
58. McKinney T.D., Desjardins C. Postnatal development of the testis and fighting behaviour and fertility in mice. Biological Reproduction. 9:1973;279-294.
59. Dixon A.K., Fish H.U., McAllister K.H. Ethopharmacology: a biological approach to the study of drug-induced changes in behavior. Adv Study Behav. 19:1990;171-183.
60. Haber S.B., Simmel E.C. Tail rattling and agonistic behavior in mice: coincidental or causal? Bull Psychon Soc. 7:1976;84-86.
61. Krsiak M. Tail rattling in aggressive mice as a measure of tranquillizing activity of drugs. Activ Nerv Sup. 17:1975;225-226.
62. Galef B.G. The ecology of weaning: parasitism and the achievement of independence by altricial mammals. Gubernick D.J., Klopfer P.H. Parental care in mammals. 1981;211-241 Plenum Press, New York.
63. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res. 77:1996;23-43.
64. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet. 12:1996;81-84.
65. Laviola G., Dell'Omo G., Alleva E., Bignami G. Ontogeny of cocaine hyperactivity and conditioned place preference in mice. Psychopharmacology. 107:1992;221-228.
66. Laviola G., Dell'Omo G., Chiarotti F., Bignami G. d-Amphetamine conditioned place preference in developing mice: relation with changes in activity and stereotypies. Behav Neurosci. 108:1994;514-524.
67. Laviola G., Adriani W. Evaluation of unconditioned novelty seeking and d-amphetamine conditioned motivation in mice. Pharmacol Biochem Behav. 59:1998;1011-1020.
68. Hughes R.N. Behavior of male and female rats with free choice of two environments differing in novelty. Animal Behav. 16:1968;92-96.
69. Glickman S.E., Schiff B.B. A biological theory of reinforcement. Psychol Rev. 74:1967;81-109.
70. Glick S.D., Milloy S. Rate-dependent effects of d-amphetamine on locomotor activity in mice: possible relationship to paradoxical amphetamine sedation in minimal brain dysfunctions. Eur J Pharmacol. 24:1973;266-268.
71. Laviola G., Wood R.D., Kuhn C., Francis R.L.P. Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther. 275:1995;345-357.
72. Lett B.T. Enhancement of conditioned preference for a place paired with amphetamine produced by blocking the association between place and amphetamine-induced sickness. Psychopharmacology. 95:1988;390-394.
73. Kelly P.H., Seviour P.W., Iversen S. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
74. Staton D.M., Solomon P.R. Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotipy and locomotion in the rat. Physiol Psychol. 12:1994;159-162.
75. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev. 94:1987;469-492.
76. Jones G.J., Mittleman G., Robbins T.W. Attenuation of amphetamine-stereotypy by mesostriatal dopamine depletion enhances plasma corticosterone: implications for stereotypy as a coping response. Behav Neural Biol. 51:1989;80-91.
77. Mittleman G., Jones G.H., Robbins T.W. Sensitization of amphetamine-stereotypy reduces plasma corticosterone: implications for stereotypy as a coping response. Behav Neural Biol. 56:1991;170-182.
78. Wall A., Hinson R.E., Schmidt E., Johnson C., Streather A. Place conditioning with d-amphetamine: the effect of the CS-UCS interval and evidence of a place avoidance. Anim Learn Behav. 18:1990;393-400.
79. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol. 4:1993;289-312.
80. Goudie A.J., Emmett-Oglesby M.W. Psychoactive drugs: tolerance and sensitization. 1989;Humana Press, New Jersey.
81. Deminiere J.M., Piazza P.V., LeMoal M., Simon H. Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci Biobehav Rev. 13:1989;141-147.
82. Koff J.M., Shuster L., Miller L.G. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exper Ther. 268:1994;277-282.
83. Laviola G., Dell'Omo G. Precocious weaning and changes in social variables during pre-puberty affect cocaine reinforcing properties in adult mice. Psychobiology. 25:1997;163-170.
84. Laviola G., Renna G., Bignami G., Cuomo V. Ontogenetic and pharmacological dissociation of various components of locomotor activity and habituation in the rat. Int J Dev Neurosci. 6:1988;431-438.
85. Spear L.P., Enters E.K., Linville D.G. Age-specific behaviors as tools for examining teratogen-induced neural alterations. Neurobehav Toxicol Teratol. 7:1985;691-695.
86. Weiss R.D., Mirin S.M., Bartel R.L. Cocaine. 1994;American Psychiatric Press, Washington, DC.
87. Estroff T.W., Schwartz R.H., Hoffman N.G. Adolescent cocaine abuse: addictive potential, behavioral and psychiatric effects. Clin Pediatr. 28:1989;550-555.
88. Johanson C., Fishman M.W. The pharmacology of cocaine related to its abuse. Pharmacol Rev. 41:1989;3-52.
89. McDougall S.A., Duke M.A., Bolanos C.A., Crawford C.A. Ontogeny of behavioral sensitization in the rat. Effects of direct and indirect dopamine agonists. Psychopharmacology. 116:1994;483-490.
90. Wood R.D., Tirelli E., Snyder K.J., Heyser C.J., LaRocca T.M., Spear L.P. Evidence for behavioral sensitization to cocaine in preweanling rat pups. Psychopharmacology. 138:1998;114-123.
91. Mason G.J. Stereotypies: a critical review. Anim Behav. 41:1991;1015-1037.
92. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol. 4:1993;315-334.
93. 3H-DA release by D2 autoreceptors. Pharmacol Biochem Behav. 36:1990;457-461.
94. Trent F., Nakamura S., Tepper J.M. Amphetamine exerts anomalous effects on dopaminergic neurons in neonatal rats in vivo. Eur J Pharmacol. 204:1991;265-272.
95. Lin M., Walters D.E. Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age. Psychopharmacology. 11:1994;262-268.
96. Shalaby I.A., Dendel P.S., Spear L.P. Differential functional ontogeny of presynaptic receptor regulation. Dev Brain Res. 1:1981;434-439.
97. Becker J.B., Robinson T.E., Lorens K.A. Sex differences and estrus cycle variations in amphetamine-elicited rotational behavior. Eur J Pharmacol. 80:1982;65-72.
98. Handa R.J., Burgess L.H., Kerr J.E., O'Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav. 28:1994;464-476.
99. Handa R.J., Nunley K.M., Lorens S.A., Louie J.P., Mcgivern R.F., Bolnow M.R. Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors. Physiol Behav. 55:1994;117-124.
100. Robinson T.E., Becker J.B., Presty S.K. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res. 253:1982;231-241.
101. Forgie M.L., Stewart J. Sex differences in the locomotor-activating effects of amphetamine: role of circulating testosterone in adulthood. Physiol Behav. 56:1994;639-644.
102. Fuller R.W., Snoddy H.D., Mason N.R., Clemens J.A., Bemis K.G. Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide. Neuroendocrinology. 36:1983;285-290.
103. Fuller R.W., Snoddy H.D. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology. 109:1981;1026-1032.
104. Casolini P., Kabbaj M., Leprat F., Piazza P., Rouge-Pont F., Angelucci L., Simon H., Le Moal M., Maccari S. Basal and stress-induced corticosterone secretion is decreased by lesion of mesencephalic dopaminergic neurons. Brain Res. 622:1993;311-314.
105. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Ann Rev Pharmacol Toxicol. 36:1996;359-378.
106. Piazza P.V., Le Moal M. The role of stress in drug self-administration. Tr Pharmacol Sci. 19:1998;67-74.
107. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA. 88:1991;2088-2092.
108. Badiani A., Morano M.I., Akil H., Robinson T.E. Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine. Brain Res. 673:1995;13-24.
109. Piazza P.V., Deroche V., Deminiere J.M., Maccari S., Le Moal M., Simon H. Corticosterone in the range of stress-induced levels possess reinforcing properties: implications for sensation-seeking behaviors. Proc Natl Acad Sci USA. 90:1993;11 738-11 742.
110. Swerdlow N.R., Koob G.F., Cador M., Lorang M., Hauger R.L. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav. 45:1993;629-637.
111. Welker W.I. Free versus forced exploration of a novel situation by rats. Psychol Rep. 3:1957;95-108.
112. Griebel G., Belzung C., Misslin R., Vogel E. The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia reducing drugs. Behav Pharmacol. 4:1993;637-644.
113. Misslin R., Herzog F., Koch B., Ropartz P. Effects of isolation, handling and novelty on the pituitary-adrenal response in the mouse. Psychoneuroendocrinology. 7:1982;217-221.
114. Blanchard R.J., Kelley M.J., Blanchard D.C. Defensive reactions and exploratory behavior in rats. J Comp Physiol Psychol. 87:1974;1129-1133.
115. Exner M., Clark D. Behaviour in the novel environment predicts responsiveness to d-amphetamine in the rat: a multivariate approach. Behav Pharmacol. 4:1993;47-56.
116. File S.E., Peet L.A. The sensitivity of the rat corticosterone response to environmental manipulations and to chronic chlordiazepoxide treatment. Physiol Behav. 25:1980;753-758.
117. Hennessy M.B., Heybach J.P., Vernikos J., Levine S. Plasma corticosterone concentrations sensitively reflect levels of stimulus intensity in the rat. Physiol Behav. 22:1979;821-825.
118. Cirulli F., Adriani W., Laviola G. Sexual segregation in infant mice: behavioral and neuroendocrine responses to d-amphetamine administration. Psychopharmacology. 134:1997;140-152.
119. Campbell A., Baldessarini R.J., Teicher M.H. Decreasing sensitivity to neuroleptic agents in developing rats: evidence for a pharmacodynamic factor. Psychopharmacology. 94:1988;46-51.
120. Andersen S.L., Gazzara R.S. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects of spontaneous release. J Neurochem. 61:1993;2247-2255.
121. Nomura Y., Yotsumoto I., Oki K. Age-related changes in the central catecholaminergic function and its interaction with methamphetamine during postnatal life in the rat. J Pharm Pharmacol. 33:1981;264-266.
122. Shalaby I.A., Spear L.P. Psychopharmacological effects of low and high doses of apomorphine during ontogeny. Eur J Pharmacol. 67:1980;451-459.
123. Gazzara R.A., Andersen S.L. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on potassium-evoked release. Neurochem Res. 19:1994;339-345.
124. Armfred T., Randrup A. Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior. Acta Pharmacol Toxicol. 26:1968;384-394.
125. Decsi L., Nagy J. Independent GABAergic and cholinergic modulation of apomorphine-induced stereotyped rearing in the rat. Neuropharmacology. 27:1988;281-285.
126. Wickens J. Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model. J Neural Transm. 80:1990;9-31.
127. Lehman J., Langer S.Z. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience. 10:1983;1105-1120.
128. Henning S.J. Plasma concentrations of total and free corticosterone during development in the rat. Am J Physiol. 235:1978;E451-E456.
129. Flickinger C.J., Herr J.C., Baran M.L., Howards S.S. Testicular development and the formation of spermatic granulomas of the epididymis after obstruction of the vas deferens in immature rats. J Urol. 154:1995;1539-1544.
130. Rosenfeld P., Suchecki D., Levine S. Multifactorial regulation of the hypothalamic-pituitary-adrenal axis during development. Neurosci Biobehav Rev. 16:1992;553-568.
131. Stone E.A., Quatermain D. Greater behavioral effect of stress in immature as compared to mature male mice. Physiol Behav. 63:1988;143-145.
132. Knyck E.T., Eisenberg R.M. Effect of amphetamine on plasma corticosterone in the conscious rat. Neuroendocrinology. 29:1979;110-118.
133. Kitchen I., Kelly M., Turner M. Dopamine receptor modulation of corticosterone secretion in neonatal and adult rats. J Pharm Pharmacol. 40:1988;580-581.
134. Choi S., Kellogg C.K. Adolescent development influences functional responsiveness of noradrenergic projections to the hypothalamus in male rats. Dev Brain Res. 94:1996;144-151.
135. Choi S., Weisberg S.N., Kellogg C.K. Control of endogenous norepinephrine release in the hypothalamus of male rats changes over adolescent development. Dev Brain Res. 98:1997;134-141.
136. Wurbel H., Staffaucher M., Von Holst D. Stereotypies in laboratory mice: quantitative and qualitative description of the ontogeny of wire gnawing and jumping in Zur:ICR and Zur:ICR nu. Ethology. 102:1996;371-385.
137. Teicher M., Andersen S.L., Hostetter J.C. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res. 89:1995;167-172.
138. Teicher M.H., Andersen S.L., Glod C.A., et al. Neuropsychiatric disorders of childhood and adolescence. Yudofsky S.C., Hales R.E., et al. Textbook of neuropsychiatry. 3 :1997;903-941.
139. Seeman P., Bzowej N., Guan H., Bergeron C., Becker L.E., Reynolds G.P., Bird E.D., Riedere P., Jellinger K., Watanabe S., Tourtellotte W.W. Human brain receptors in children and aging adults. Synapse. 1:1987;399-404.
140. Spangler R., Zhou Y., Schlussman S.D., Ho A., Kreek M.J. Behavioral stereotypies induced by a binge cocaine administration are independent of drug-induced increases in corticosterone levels. Behav Brain Res. 86:1997;201-204.
141. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. TINS. 20:1997;78-84.
142. Infurna R.N., Spear L.P. Developmental changes in amphetamine-induced taste aversions. Pharmacol Biochem Behav. 11:1979;31-35.
143. Ramsay D.S., Woods S.C. Biological consequences of drug administration: implications for acute and chronic tolerance. Psychol Rev. 104:1997;170-193.